<!DOCTYPE html>
<html lang = "en">


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />


  
  <!-- fetch the title & body fonts immediately to avoid re-rendering -->

  <link rel="preload" as="style"      href="/static/css/default.css" />
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-Bold.ttf"           as="font" type="font/ttf" crossorigin="anonymous">
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-Regular.ttf"        as="font" type="font/ttf" crossorigin="anonymous">
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-Semibold.ttf"       as="font" type="font/ttf" crossorigin="anonymous">
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-SemiboldItalic.ttf" as="font" type="font/ttf" crossorigin="anonymous">
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-RegularItalic.ttf"  as="font" type="font/ttf" crossorigin="anonymous">
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-BoldItalic.ttf"     as="font" type="font/ttf" crossorigin="anonymous"> 
<style>
  @font-face {
      font-family: 'Source Serif Pro';
      font-weight: 400;
      font-style: normal;
      src: url('font/ssfp/SourceSerif4-Regular.ttf.woff') format('woff');
      src: url('/static/font/ssfp/SourceSerifPro-BASIC-Regular.ttf') format('truetype');
      unicode-range: U+0020-007E, U+2010, U+2013-2014, U+2018-2019, U+201C-201D;
      font-display: swap
  }
  @font-face {
      font-family: 'Source Serif Pro';
      font-weight: 400;
      font-style: italic;
      src: url('font/ssfp/SourceSerif4-Regular.ttf.woff') format('woff');
      src: url('/static/font/ssfp/SourceSerifPro-BASIC-RegularItalic.ttf') format('truetype');
      unicode-range: U+0020-007E, U+2010, U+2013-2014, U+2018-2019, U+201C-201D;
      font-display: swap;
  }
  @font-face {
      font-family: 'Source Serif Pro';
      font-weight: 600;
      font-style: normal;
      src: url('font/ssfp/SourceSerif4-It.ttf.woff') format('woff');
      src: url('/static/font/ssfp/SourceSerifPro-BASIC-Semibold.ttf') format('truetype');
      unicode-range: U+0020-007E, U+2010, U+2013-2014, U+2018-2019, U+201C-201D;
      font-display: swap
  }
  @font-face {
      font-family: 'Source Serif Pro';
      font-weight: 700;
      font-style: normal;
      src: url('font/ssfp/SourceSerif4-SemiboldIt.ttf.woff') format('woff');
      src: url('/static/font/ssfp/SourceSerifPro-BASIC-Bold.ttf') format('truetype');
      unicode-range: U+0020-007E, U+2010, U+2013-2014, U+2018-2019, U+201C-201D;
      font-display: swap
  }

  </style>
 

  <meta name="author" content="James Maye" />
  <meta name="title" content="Chromosome Abnormalities in Leukaemia">
  <meta name="generator" content="Pandoc">

  <link rel="stylesheet" type="text/css" href="/static/css/default.css" />
  <link rel="icon" type="image/png" href="/static/img/m.png" />
  
  <title>Chromosome Abnormalities in Leukaemia · James Maye</title>


</head>



<body>
    <main>
       
<!-- Navbar Goes here -->
        <div id="nav">

            <div id="navbar">

                <div>
                    <a href="/medicine">Medicine</a>
                </div>

                <div>
                    <a href="/">JM</a>
                </div>

                <div>
                    <a href="">Chapter</a>
                </div>


                </div>
            </div> 
<!-- End navbar -->
    	

     <header id="top">
         <h1>Chromosome Abnormalities in Leukaemia</h1>
     </header>

     <article>
<!-- Top matter start -->
         <div id="page-metadata">
             <p>
                 <span id="page-description" title="Short summary of article."><em>A table describing the major chromosome abnormalities occurring in different leukaemias.</em></span>
                 <br/>
                 <span id="tags" title="Tags list"><em>
                     <a href="/tags/medicine">medicine</a>, <a href="/tags/haematology">haematology</a>, <a href="/tags/cancer">cancer</a>, <a href="/tags/leukaemia">leukaemia</a>
                 </em></span>
                 <br/>
                 <span id="page-metadata-block">
                     
                     <!-- Date created - date modified -->
                     <span id="page-date-range"><span id="page-creation" title="Date page contents were begun."><em>27/02/2021</em></span> &ndash;  <!--endash with space either side--><span id="page-source"><a title="Link to latest revision of the raw Markdown text source for this page, 'Chromosome Abnormalities in Leukaemia': chromosome-abnormalities-in-leukaemia.md" href="chromosome-abnormalities-in-leukaemia.md"><span id="page-modified" title="Date of last major modification to this page."><em>27/02/2021</em></span></a></span></span>
                     
                     <span id="page-status" title="Status of current page: 'abandoned/notes/in progress/finished'"><em>finished</em></span>
                </span> <!-- page-metadata-block end-->     
             </p>
             <hr>
         
         </div> <!-- page-metadata end -->
<!-- Top matter end -->
         <div id="md-body">
    
<p>Cytogenetic (chromosomal) abnormalities are found in two-thirds of <span class="JM-link"><a href="acute-myeloid-leukaemia">Acute Myeloid Leukaemia</a></span> (AML) cases and three-quarters of <span class="JM-link"><a href="acute-lymphoblastic-leukaemia">Acute Lymphoblastic Leukaemia</a></span> (ALL) cases. Many of the chromosomal abnormalities in leukaemia and lymphoma are translocations, where genetic material is exchanged between two chromosomes.</p>
<p>Chromosome abnormalities confer particular prognostic significance. For example, the Philadelphia chromosome t(9;22) confirms particulalry poor prognosis when seen in childhood ALL. The t(8;21) translocation generally implies good prognosis in adult AML meanwhile, generally meaning that bone marrow transplantation will not be required.</p>
<p>Chromosome abnormalities can also be used as a marker of disease, and a sign of relapse. The abnormal DNA sequence signal can be amplified using PCR, making this a much more sensitive test in detecting residual leukaemia than through cytology.</p>
<table style="width:86%;">
<colgroup>
<col style="width: 33%" />
<col style="width: 52%" />
</colgroup>
<thead>
<tr class="header">
<th>Chromosome abnormality</th>
<th style="text-align: left;">Condition</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>t(9;22)</td>
<td style="text-align: left;">Philadelphia chromosome. Commonly seen in CML, confers poor prognosis in ALL.</td>
</tr>
<tr class="even">
<td>t(15;17)</td>
<td style="text-align: left;">APML (AML M3) - treated with ATRA</td>
</tr>
<tr class="odd">
<td>t(8;21)</td>
<td style="text-align: left;">AML with some differentiation (M2) – confers better prognosis</td>
</tr>
<tr class="even">
<td>Hyperdiploidy (&gt;47 chromosomes)</td>
<td style="text-align: left;">Childhood ALL: better prognosis</td>
</tr>
<tr class="odd">
<td>t(8;14) &lt;</td>
<td style="text-align: left;">span class=‘JM-link’&gt;<a href="burkitt-lymphoma">Burkitt lymphoma</a></span></td>
</tr>
<tr class="even">
<td>5q- L M a r</td>
<td style="text-align: left;">oss of long arm of Ch. 5. yelodysplastic syndrome (refractory naemia) with abnormal megakaryocytes esponds to lenalidomide</td>
</tr>
<tr class="odd">
<td>t(14;18) Fo in</td>
<td style="text-align: left;">llicular Non-Hodgkin lymphoma – seen 75% of cases.</td>
</tr>
</tbody>
</table>
<!-- {BearID:10536D95-6F42-4BCE-B686-6680ADB7BA7A-1211-0000EA9C2D4AB6E3} -->

         </div> <!-- div id="md-body" -->
    </article>

</main>
</body>
</html>


